Speakers

Keynote Speakers

Chad A. Mirkin, Ph.D., Professor Materials Science and Engineering Director of the International Institute for Nanotechnology Northwestern University
Thomas Steitz, Ph.D. Sterling Professor of Molecular Biophysics and Biochemistry Professor of Chemistry Investigator, Howard Hughes Medical Institute Yale University
Christopher T. Walsh, Ph.D. Hamilton Kuhn Professor of Biological Chemistry and Molecular Pharmacology Harvard Medical School, USA

Speaker & Institution	Presentation Title

*Drug Discovery Track (Natural Products, Medicinal Chemistry, Pharmacology)*
Zhong Chen, Ph.D. Executive Dean of College of Pharmaceutical Science Vice Dean of School of Medicine Vice Director of Ministry of Health Key Lab of Neurobiology College of Pharmacy, Zhejiang University, China	Effect of Histamine and its Receptors on Brain Ischemia and Designing Histamine 3 Antagonists
Iqbal Choudhary, Ph.D., Director International Center for Chemical and Biological Sciences University of Karachi, Pakistan	Nature's Chemical Diversity-Role in Drug Discovery and Development
Ahmed Kamal, Ph.D., Outstanding Scientist CSIR-Indian Institute of Chemical Technology [IICT] Tarnaka, Hyderabad, India	Challenges in the Development of Pyrrolobenzodiazepines as Anti-tumour Antibiotics
Anil Kumar, Ph.D., Assistant Professor Department of Chemistry Birla Institute of Technology & Science, Pilani Campus, India	Synthesis and Evaluation of Quebecol
Mahesh K. Lakshman, Ph.D., Professor Department of Chemistry The City College of New York, USA	Synthesis of Azidopurine Nucleosides and their Ligation Reactions with Alkynes: Towards New Potential Pharmacological Agents
Süreyya Ölgen, Ph.D., Vice Dean Department of Pharmaceutical and Medicinal Chemistry University of Ankara, Turkey	Design and Synthesis of Novel Small Molecules as Src Kinase Inhibitors
Ashok Prasad, Ph.D., Professor Department of Chemistry University of Delhi, India	Glucose to Modified Nucleosides and Sugar-PEG Based Co-Polymer for Drug Delivery Applications
Sunil Sharma, Ph.D., Professor Department of Chemistry University of Delhi, India	Ammonium Derivatives of Chromenones and Quinolinones as Lead Antimicrobial Agents
Tej P. Singh, Ph.D., Distinguished Biotechnology Research Professor Department of Biophysics All India Institute of Medical Sciences, India	1. Drug Discovery: Structure and Action of Bacterial Resistance Free Novel Protein Antibiotic - PGRP-S 2. Structure-based Drug-design using Proteins of Pro-inflammatory Pathway as Targets
Young-Joon Surh, Ph.D., Director and Professor Tumor Microenvironment Global Core Research Center College of Pharmacy Seoul National University, South Korea	Phytopharmaceuticals: from Discovery to Therapeutic Applications
Francisco A. Tomás-Barberán, Ph.D., Professor Department Food Science & Technology Campus de Espinardo, Murcia, CEBAS-CSIC, Spain	Natural Product Derived Gut Microbacteria Metabolites as Potential Drugs: The Case of Urolithins
Akhilesh K. Verma, Ph.D., Associate Professor Department of Chemistry University of Delhi, India	Electrophilic Cyclization of Alkynes: A Modern Tool for the Synthesis of Small Heterocyclic Molecules of Pharmaceutical Interest
Hermann Wätzig, Ph.D., Professor Institute for Chemical and Thermal Process Engineering University of Braunschweig, Germany	Proteomics and Interactomics in Drug Discovery or Drug Development
Gerhard Wolber, Ph.D., Professor Institute of Pharmacy Freie University, Berlin, Germany	Virtual Screening and Activity Profiling Using 3D Pharmacophores
Jhillu Singh Yadav, Ph.D., Director Indian Institute of Chemical Technology, Hyderabad, India	Natural Product Synthesis for Drug Discovery

*Drug Development Track*
Tommy B. Andersson, Ph.D. Senior Principal Scientist, DMPK Center of Excellence CVGI iMed DMPK, AstraZeneca R&D, Mölndal, Sweden	The Evolution of CYP Induction Models to Support Drug Development
Pravin R. Chaturvedi, Ph.D., CEO, IndUS Pharmaceuticals, USA	Drug Development from the Prospect of Small Biotech Companies
Annie S. De Groot, M.D., Research Professor University of Rhode Island, USA Director, Institute for Immunology and Informatics, EpiVax, USA	Is There No Balm in Bamako, Mali? Keeping Drug and Vaccine Development in Perspective
David J. Greenblatt, M.D. Louis Lasagna Professor of Pharmacology and Experimental Therapeutics Department of Molecular Physiology and Pharmacology Tufts University, USA	Altered Drug Disposition and Response in Old Age: Experimental and Clinical Models
Ronald N. Hines, Ph.D., Professor Chief Pediatrics - Pharmacogenetics Department of Pharmacology and Toxicology Medical College of Wisconsin, USA	Pharmacological Challenges During Early Life Stages
Brian Houston, Ph.D., DSc, Professor School of Pharmacy and Pharmaceutical Sciences University of Manchester, UK	Predictive Hepatocellular Activity: Cornerstone for PBPK Modeling
Richard Lalonde, Pharm.D., VP and Global Head of Clinical Pharmacology Pfizer Inc., USA	Modeling and Simulation in Clinical Drug Development
Kazuya Maeda, Ph.D., Assistant Professor	The importance of OATP transporters in the clinical pharmacokinetics of anionic drugs
Vincent Pichette, M.D., Ph.D., Professor Department of Pharmacology University of Montreal, Canada	Impact of Kidney Disease on Drug Metabolism and Transport
Chandra Prakash, Ph.D., Senior Director Drug Metabolism and Pharmacokinetics Biogen Idec, USA	The Strategies for Minimization of Bioactivation Potential in Drug Discovery and Development.
Matthias Schwab, M.D., Professor and Chair of Clinical Pharmacology Head of the Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart Department of Clinical Pharmacology, Institute of Experimental and Clinical Pharmacology and Toxicology University Hospital, Tübingen, Germany	Pharmacogenomics of Uptake Transporters and Clinical Implications
Terry Smolarek, Ph.D., Senior Director Pfizer Research & Development, USA	Ethnic Differences in Pharmacokinetics
Karthik Venkatakrishnan, Ph.D., Director Clinical Pharmacy Millennium: The Takeda Oncology Company, USA	Drug-Drug Interactions (DDIs) in the Development of Anticancer Drugs: Strategies for Risk Assessment, Management and Clinical Evaluation

who should attend?

Drug discovery, delivery, and development scientists
Pharmaceutical scientists
Academic and industrial researchers
Students and postdoctoral fellows involved in pharmaceutical sciences

Registration

Attendee Registration

questions?

Please send an email to:

Dr. Keykavous Parang or Dr. Navindra Seeram at Frontiers@etal.uri.edu

College of Pharmacy - 2012 Frontiers in Pharmaceutical Sciences Conference

Speakers

who should attend?

Registration

questions?

Conference Sponsors